Roche snags first-in-class FDA nod for lymphoma drug Polivy
admin 10th June 2019 Uncategorised 0Roche’s top-selling trio of cancer blockbusters face biosim attack in the U.S. this year, but the Swiss drugmaker just scored an FDA nod for a brand-new oncology drug that might help it pick up the sales slack.
More: Roche snags first-in-class FDA nod for lymphoma drug Polivy
Source: fierce